JON S. SAXE - 01 Mar 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
01 Mar 2022
Transactions value $
$0
Form type
4
Filing time
03 Mar 2022, 15:12:01 UTC
Next filing
06 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Award $0 +100K $0.00 100K 01 Mar 2022 Common Stock 100K $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, which vest in twelve equal monthly installments, beginning on the date of the grant.